<p>PALO ALTO, Calif., Aug 19, 2010 (GlobeNewswire via COMTEX) — StemCells, Inc. /quotes/comstock/15*!stem/quotes/nls/stem (STEM 0.92, -0.03, -3.27%) announced today the publication of new preclinical data demonstrating that the Company’s proprietary human neural stem cells restore lost motor function in mice with chronic spinal cord injury. This is the first published study to show that human neural stem cells can restore mobility even when administered at time points beyond the acute phase of trauma, suggesting the prospect of treating a much broader population ..</p>